FIELD: medicine.
SUBSTANCE: what is offered is the use of viferon as an agent for prevention of postoperative laryngeal paresis following thyroidectomy.
EFFECT: minimised risk of postoperative laryngeal paresis following thyroidectomy with preserved anatomical continuity of recurrent laryngeal nerves, as well as adequate reduction of the rate of postoperative hypocalcemia from 38% to 32%.
2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SURGICAL TREATMENT OF THYROID CANCER WITH METASTASES TO THE LYMPH NODES OF THE CENTRAL TISSUE OF THE NECK | 2022 |
|
RU2800313C1 |
METHOD OF VIDEO-ASSISTED MEDIASTINAL LYMPHADENECTOMY | 2008 |
|
RU2381753C1 |
METHOD OF TREATMENT OF TEMPORAL POSTOPERATIVE PARESIS OF RECURRENT LARYNGEAL NERVE IN EXTENSIVE THYROID GLAND SURGERY | 2007 |
|
RU2348403C1 |
METHOD OF EXTRAFASCIAL REMOVAL OF LOBE OF THYROID GLAND | 2007 |
|
RU2357684C1 |
METHOD OF PREVENTING COMPLICATION IN SURGICAL TREATMENT OF THYROID GLAND DISEASES | 2011 |
|
RU2458639C1 |
METHOD FOR SURGICAL TREATMENT OF THYROID DISEASES | 2004 |
|
RU2257857C1 |
METHOD FOR PREVENTION OF RECURRENT LARYNGEAL NERVE DAMAGE IN POSTOPERATIVE PERIOD DURING HEMITHYROIDECTOMY OR THYROIDECTOMY | 2023 |
|
RU2820260C1 |
METHOD FOR SURGICAL TREATMENT OF THYROID CANCER IN THYROTOXICOSIS | 2020 |
|
RU2751971C1 |
METHOD OF THYROID RESECTION AT TOXIC GOITER | 2007 |
|
RU2339315C1 |
METHOD FOR DIAGNOSING THE RISK OF DAMAGE TO THE RECURRENT NERVE WHEN REMOVING A LOBE OR THE ENTIRE THYROID GLAND | 2021 |
|
RU2782654C1 |
Authors
Dates
2012-04-10—Published
2010-12-01—Filed